Sarepta Therapeutics Inc. Common Stock (DE) monthly returns
Sarepta Therapeutics Inc. Common Stock (DE) has averaged 2.73% per month, positive in 48% of months. Month-by-month returns for Sarepta Therapeutics Inc. Common Stock (DE) (SRPT) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Sarepta Therapeutics Inc. Common Stock (DE) monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -6.1% | |
| Sep 2026 | -13.4% | |
| Aug 2026 | +41.5% | |
| Jul 2026 | -17.3% | |
| Jun 2026 | +0.6% | |
| May 2026 | -14.4% | |
| Apr 2026 | -4.0% | |
| Mar 2026 | +29.8% | |
| Feb 2026 | -17.6% | |
| Jan 2026 | -5.5% | |
| Dec 2025 | +0.8% | |
| Nov 2025 | -11.1% | |
| Oct 2025 | +24.6% | |
| Sep 2025 | +5.9% | |
| Aug 2025 | +10.8% | |
| Jul 2025 | -4.0% | |
| Jun 2025 | -54.5% | |
| May 2025 | -39.7% | |
| Apr 2025 | -2.2% | |
| Mar 2025 | -40.2% | |
| Feb 2025 | -6.1% | |
| Jan 2025 | -6.5% | |
| Dec 2024 | -8.8% | |
| Nov 2024 | +5.8% | |
| Oct 2024 | +0.9% | |
| Sep 2024 | -8.0% | |
| Aug 2024 | -4.5% | |
| Jul 2024 | -10.0% | |
| Jun 2024 | +21.7% | |
| May 2024 | +2.5% | |
| Apr 2024 | -2.2% | |
| Mar 2024 | +1.2% | |
| Feb 2024 | +7.5% | |
| Jan 2024 | +23.4% | |
| Dec 2023 | +18.6% | |
| Nov 2023 | +20.8% | |
| Oct 2023 | -44.5% | |
| Sep 2023 | +0.2% | |
| Aug 2023 | +11.6% | |
| Jul 2023 | -5.4% | |
| Jun 2023 | -7.3% | |
| May 2023 | +0.7% | |
| Apr 2023 | -10.9% | |
| Mar 2023 | +12.9% | |
| Feb 2023 | -2.3% | |
| Jan 2023 | -3.6% | |
| Dec 2022 | +5.5% | |
| Nov 2022 | +7.7% | |
| Oct 2022 | +3.1% | |
| Sep 2022 | +1.1% | |
| Aug 2022 | +17.7% | |
| Jul 2022 | +24.0% | |
| Jun 2022 | +2.9% | |
| May 2022 | +0.7% | |
| Apr 2022 | -7.4% | |
| Mar 2022 | +2.0% | |
| Feb 2022 | +7.0% | |
| Jan 2022 | -20.5% | |
| Dec 2021 | +11.4% | |
| Nov 2021 | +2.1% | |
| Oct 2021 | -14.4% | |
| Sep 2021 | +18.4% | |
| Aug 2021 | +15.3% | |
| Jul 2021 | -12.8% | |
| Jun 2021 | +2.8% | |
| May 2021 | +6.8% | |
| Apr 2021 | -5.0% | |
| Mar 2021 | -14.4% | |
| Feb 2021 | -2.6% | |
| Jan 2021 | -47.6% | |
| Dec 2020 | +21.0% | |
| Nov 2020 | +3.6% | |
| Oct 2020 | -3.2% | |
| Sep 2020 | -4.1% | |
| Aug 2020 | -4.6% | |
| Jul 2020 | -4.3% | |
| Jun 2020 | +5.3% | |
| May 2020 | +29.2% | |
| Apr 2020 | +20.5% | |
| Mar 2020 | -14.5% | |
| Feb 2020 | -1.3% | |
| Jan 2020 | -10.1% | |
| Dec 2019 | +14.7% | |
| Nov 2019 | +35.4% | |
| Oct 2019 | +10.3% | |
| Sep 2019 | -16.5% | |
| Aug 2019 | -39.4% | |
| Jul 2019 | -2.0% | |
| Jun 2019 | +33.5% | |
| May 2019 | -2.6% | |
| Apr 2019 | -1.9% | |
| Mar 2019 | -17.4% | |
| Feb 2019 | +3.2% | |
| Jan 2019 | +28.0% | |
| Dec 2018 | -15.7% | |
| Nov 2018 | -3.2% | |
| Oct 2018 | -17.2% | |
| Sep 2018 | +17.0% | |
| Aug 2018 | +18.8% | |
| Jul 2018 | -12.1% | |
| Jun 2018 | +40.8% | |
| May 2018 | +22.9% | |
| Apr 2018 | +3.1% | |
| Mar 2018 | +18.0% | |
| Feb 2018 | -4.2% | |
| Jan 2018 | +17.8% | |
| Dec 2017 | -0.1% | |
| Nov 2017 | +12.9% | |
| Oct 2017 | +8.7% | |
| Sep 2017 | +12.6% | |
| Aug 2017 | +4.4% | |
| Jul 2017 | +14.4% | |
| Jun 2017 | +13.0% | |
| May 2017 | -17.7% | |
| Apr 2017 | +22.5% | |
| Mar 2017 | -4.9% | |
| Feb 2017 | +0.2% | |
| Jan 2017 | +13.2% | |
| Dec 2016 | -19.9% | |
| Nov 2016 | -12.7% |
Monthly total return (since Nov 2021)#
Sarepta Therapeutics Inc. Common Stock (DE) returns by calendar month#
Every month of every year since 1998, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -6.15% — 17th of 29 Octobers since 1998 at the last close; the average October returned -1.9%.
| Month | −150%0+150% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +9.1% | +1.2% | 52% | +147.0% 2006 | -69.2% 2016 | |
| Feb | +1.6% | -1.4% | 41% | +126.1% 2000 | -33.9% 2003 | |
| Mar | -0.9% | -4.2% | 41% | +48.1% 2012 | -51.9% 2000 | |
| Apr | +3.5% | -2.2% | 38% | +82.0% 2003 | -46.1% 2012 | |
| May | +3.8% | -2.6% | 48% | +110.0% 2015 | -39.7% 2025 | |
| Jun | +1.0% | +0.6% | 52% | +40.8% 2018 | -54.5% 2025 | |
| Jul | +4.3% | -2.8% | 45% | +139.9% 2012 | -29.7% 2000 | |
| Aug | +6.2% | +7.2% | 62% | +74.4% 2012 | -39.4% 2019 | |
| Sep | +4.7% | -2.3% | 45% | +135.6% 2016 | -24.4% 2004 | |
| Oct | -1.9% | -0.6% | 50% | +37.3% 2012 | -44.5% 2023 | |
| Nov | +3.3% | -1.0% | 50% | +66.2% 1999 | -52.1% 2013 | |
| Dec | -1.9% | +2.1% | 57% | +21.0% 2020 | -39.5% 2007 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from SRPT's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Sarepta Therapeutics Inc. Common Stock (DE)'s average monthly return?
- Sarepta Therapeutics Inc. Common Stock (DE) (SRPT) has averaged about 2.73% per month, positive in roughly 48% of months. The best month was Jan 2006 (+147.0%) and the worst was Jan 2016 (-69.2%).
